URGENT: The COVID-19 epidemic is severely impacting the progress of ALS research at the ALS Therapy Development Institute. If you are able to give, will you please provide an immediate gift to fund our lab?

 

TDI 168

Scientists at the ALS Therapy Development Institute are testing this small molecule to address the oxidative stress observed in the cells of PALS.

Status

Type: Small Molecule
Stage: Active
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

Our team is working to finalize the formulation strategy that will be used throughout the preclinical testing of this compound. 

Comment on this Topic

(All comments are moderated before they appear here.)